Robustness of MBTFM and comparison with FTTC. by Jérôme R. D. Soiné (699732)

“…By fitting the regularization parameter to a one-to-one relationship (blue), FTTC can be calibrated based on the biophysical model input instead of traditional noise optimization (red). …”

Data_Sheet_3.xlsx by Uwe Möginger (4987334)

“…<p>The glycome of one of the largest and most exposed human organs, the skin, as well as glycan changes associated with non-melanoma skin cancers have not been studied in detail to date. …”

Relationships between body mass (BM) and aspects of the digestive physiology of herbivorous vertebrates. by Marcus Clauss (280185)

“…<p>a) wet gut contents <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Clauss3" target="_blank">[79]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Franz6" target="_blank">[122]</a>; note the similarity in all three vertebrae clades, with a duck species (a flying bird) as a notable outlier; b) dry matter gut contents as calculated from simultaneous passage and digestion studies <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Mller1" target="_blank">[16]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Fritz4" target="_blank">[81]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Franz4" target="_blank">[82]</a>; note the similarity in the scaling of both measures of gut fill in all three vertebrate clades, with herbivorous birds falling into two categories (flying birds with lower gut fills; flightless or flight-reduced birds such as hoatzin and ostrich with gut fill as in mammals); c) dry matter intake in feeding studies in captivity <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Mller1" target="_blank">[16]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Fritz4" target="_blank">[81]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Franz4" target="_blank">[82]</a>; note the generally lower intake in reptiles as compared to mammals and birds; a curvature in mammals is evident with a lower scaling in smaller and a steeper scaling in larger species; d) dry matter intake (DMI, on a variety of diets) <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Mller1" target="_blank">[16]</a> or organic matter intake (OMI, on a consistent diet) <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068714#pone.0068714-Foose1" target="_blank">[66]</a> in mammal herbivores >100 kg (no smaller species included in the Foose dataset); note a tendency for a lower scaling in the Foose dataset (see text) that is not significant, raising the question whether the steeper intake scaling in larger herbivores in the Müller et al. dataset is a reaction to a putative decreasing diet quality with increasing BM.…”

DataSheet_6_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_7_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_10_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_5_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_2_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

Table_2_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_8_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_3_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

Table_3_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_9_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

Table_6_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

DataSheet_4_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

Table_5_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

Table_4_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.xlsx by Cristina Calviño (17004837)

“…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I^KO/TCR^KO CAR-T cells that would be compatible with clinical applications. …”

Transcriptomic Changes in Liver of Young Bulls Caused by Diets Low in Mineral and Protein Contents and Supplemented with n-3 Fatty Acids and Conjugated Linoleic Acid by Sara Pegolo (3387497)

“…<div><p>The aim of the present study was to identify transcriptional modifications and regulatory networks accounting for physiological and metabolic responses to specific nutrients in the liver of young Belgian Blue × Holstein bulls using RNA-sequencing. A larger trial has been carried out in which animals were fed with different diets: 1] a conventional diet; 2] a low-protein/low-mineral diet (low-impact diet) and 3] a diet enriched in n-3 fatty acids (FAs), conjugated linoleic acid (CLA) and vitamin E (nutraceutical diet). …”

Low-Temperature Oxidation of Ethylene by Ozone in a Jet-Stirred Reactor by Aric C. Rousso (5872646)

“…Here, we provide new insights into the ethylene ozonolysis reaction network via identification and quantification of previously elusive intermediates by combining experimental photoionization energy scans and <i>ab initio</i> threshold energy calculations for isomer identification. …”

Low-Temperature Oxidation of Ethylene by Ozone in a Jet-Stirred Reactor by Aric C. Rousso (5872646)

“…Here, we provide new insights into the ethylene ozonolysis reaction network via identification and quantification of previously elusive intermediates by combining experimental photoionization energy scans and <i>ab initio</i> threshold energy calculations for isomer identification. …”